AzTrials
AzTrials

Iodine Excess in PregnancyNCT03761602

The Correlation Between Iodine and Selenium Status in Pregnancy and Risk of Thyroid Disease

An observational study of Iodine Excess in Pregnancy and Selenium Excess in Pregnancy, run by Rongrong Li.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Two hundred and ninety pregnant women with gestational age less than 20 weeks will be recruited in this study. Selenium and iodine conditions, and risk of thyroid disease will be monitored until termination of pregnancy, with pregnancy outcomes recorded. Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
What is being tested?
Not applicable (for observational studies)
How many people
290 participants
Where
No sites listed yet
Study dates
1 Dec 2018to 31 Dec 2019
How long will I take part?
8 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Two hundred and ninety pregnant women with gestational age less than 20 weeks should be recruited in this study and will be followed up throughout the whole pregnancy.

Who may be able to join

  • Clinical confirmation of being pregnant.
  • Being within less than 20 weeks of gestationa.

Who cannot join

  • Being pregnant but over 20 weeks of gestationa.
  • Mentally or psychologically unstable.

About this study

Official title: The Correlation Between Iodine and Selenium Status in Pregnancy and Risk of Thyroid Disease: a Prospective Registry Study

Two hundred and ninety pregnant women with gestational age less than 20 weeks will be recruited in this study. Selenium and iodine conditions, and risk of thyroid disease will be monitored until termination of pregnancy, with pregnancy outcomes recorded.

Read the detailed description

The study will recruit 290 pregnant women with gestational age less than 20 weeks. Iodine and selenium condition will be evaluated through dietary recall (on base of Chinese food ingredient information) and biochemical examinations (serum iodine concentrations, urinary iodine concentrations, serum selenium concentrations, etc). The nutritional status of iodine and selenium will be monitored and followed up for all the included subjects throughout the pregnancy. The information of thyroid function and level of anti-TPO and anti-TG will be collected. And all the complications (especially thyroid disease) in pregnancy will also be recorded. All pregnant women will be followed up until the termination of pregnancy, with pregnancy outcomes recorded.

Being tested
Not applicable (for observational studies)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Not applicable (for observational studies)Other

    This study is an observational study. No intervention will be administered for research purposes.

Study groups in NCT03761602
Study groupRoleWhat they receive
Proper selenium and iodine conditionThe subjects should have proper dietary intake of selenium and iodine, according to Chinese Dietary Reference Intakes (DRIs) (intake of selenium 65μg/d and iodine 230 μg/d). The Serum iodine concentration are 45-92μg/L,and the urinary I/Cr 150-249μg/g Cr. The Serum selenium concentrations are 18-40μg/L.
Receives: Other: Not applicable (for observational studies)
Excessive selenium or iodine conditionThe subjects have excessive dietary intake of selenium and iodine, usually more than 2 times of DRIs. The Serum iodine concentration are more than 100μg/L,and the urinary I/Cr more than 300μg/g Cr. The Serum selenium concentrations are more than 40μg/L.
Receives: Other: Not applicable (for observational studies)
Insufficient selenium or iodine conditionThe subjects have insufficient dietary intake of either selenium or iodine, compared with DRIs. The Serum iodine concentration are less than 45μg/L,and the urinary I/Cr less than150μg/g Cr. The Serum selenium concentrations are less than 18μg/L.
Receives: Other: Not applicable (for observational studies)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. risk of thyroid disease

    prevalence of thyroid disease (abnormal thyroid function; development of thyroid antibodies)

    Measured: From date of participant inclusion until the date of termination of pregnancy, assessed up to 8 months

  2. pregnancy outcomes

    prevalence of premature birth, stillbirth and abortion

    Measured: From date of participant inclusion until the date of termination of pregnancy, assessed up to 8 months

Secondary outcomes (2)
  1. prevalence of other pregnant complications

    prevalence of gestational diabetes mellitus, gestational hypertension, dyslipidemia, etc.

    Measured: From date of participant inclusion until the date of termination of pregnancy, assessed up to 8 months

  2. prevalence of thyroid disease in neonates

    prevalence of thyroid disease (abnormal thyroid function; development of thyroid antibodies,or findings of thyroid nodules) in neonates

    Measured: From date of birth to 4 weeks after birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Dec 2018
  2. Study start1 Dec 2018 (estimated)
  3. Primary completion31 Dec 2019 (estimated)
  4. Study completion31 Dec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
290 participants (estimated)
Target duration
8 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT03761602
Sponsor's protocol ID
ISCMS
Status last verified
Nov 2018
First submitted
20 Nov 2018
Last updated
3 Dec 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Iodine Excess in Pregnancy and Selenium Excess in Pregnancy, run by Rongrong Li.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Dec 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

risk of thyroid disease (time frame: From date of participant inclusion until the date of termination of pregnancy, assessed up to 8 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in